Jennifer Byrne

It’s no secret pharmaceutical companies face a long, uphill battle to bring new drugs to market. And one of the biggest challenges is finding and engaging the right clinical trial participants. In fact, almost half of all clinical trials are delayed because of patient enrollment issues. And a staggering 94% of trials aren’t completed on…

For the past few years, value-based healthcare has been on everyone’s mind. The shift away from fee-for-service and towards value-based payment models in healthcare isn’t happening overnight, but there is a steady growth of momentum as more and more providers and health systems make the change to value.  What are the opportunities as we consider…

As healthcare costs continue to rise, there is much discussion around how we pay for the services and treatments we receive. Traditionally, physicians and providers have been compensated through a fee-for-service model, leading some to ask if we are getting the level of care and outcomes commensurate with ever-increasing healthcare spending. Within this fee-for-service model,…

Over 28 years ago, I began my work in clinical research at a small research site. It was there that I was introduced to the inner workings of clinical research and discovered my passion. In my role, I experienced firsthand the impact of clinical research for a patient participating in a trial, while also seeing…